Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.99.6 (
sialyltransferase
)
1,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1.
Cytidine
-5'-monophospho-N-acetylneuraminic acid: (galactosyl-N-acetyl-galactosaminyl-(N-acetylneuraminyl)-galactosyl-glucosylceramide
sialyltransferase
(CMP-NAcNeu: monosialoganglioside (GM1)
sialyltransferase
) activity was demonstrated in the neurohypophysis of the rabbit. 2. Optimum activity occurred at pH 6.5 and required the presence of exogenous galactosyl-N-acetylgalactosaminyl-(N-acetylneuraminyl)-galactosyl-glucosylceramide (GM1 ganglioside), detergent (Triton X-100), and divalent cation (Mn2+, Mg2+ or Ca2+). 3. The product of the reaction was characterized as N-acetylneuraminyl-galactosyl-N-acetylgalactosaminyl-(N-acetylneuraminyl)-galactosyl-glucosylceramide (GD1a) by ascending thin-layer chromatography. 4. Physiological stimulation of vasopressin secretion, by the substitution of 2.2% NaCl for drinking water for 14 days, had no effect on the enzyme activiity or the ganglioside content of the tissue.
...
PMID:Cytidine-5'-monophospho-N-acetylneuraminic acid galactosyl-N-acetylgalactosaminyl-(N-acetylneuraminyl)-galactosyl-glucosylceramide sialyltransferase in the neurohypophysis of the rabbit. 0 25
Effects of nucleotide phosphates on the
sialyltransferase
activity in the neurosensory retina of the bovine eye were studied. Enzyme activity was assayed using cytidine monophosphate-[14C]-N acetylneuraminic acid as a substrate and desialylated fetuin as an exogenous acceptor.
Cytidine
-5'-diphosphate and adenosine triphosphate inhibited the enzyme activity. Uridine diphosphate and guanosine diphosphate increased the enzyme activity at low concentrations and decreased the activity at high concentrations. Cyclic adenosine monophosphate and cyclic guanosine monophosphate increased the enzyme activity at concentrations up to 8 mM. It is thus concluded that
sialyltransferase
activity of the neural retina may be affected by various nucleotides, its alteration depending on either the type of nucleotides or their concentration.
...
PMID:The effects of pyrimidine and purine nucleotides on sialyltransferase activity in bovine neurosensory retina. 208 61
A simple and rapid procedure using anion exchange chromatography was established for determinations of the activity of ganglioside GD3 synthase (CMP-NeuAc: GM3, alpha 2----8
sialyltransferase
) which catalyzes the conversion of ganglioside GM3 to GD3. The procedure was applicable for determination of activity of other ganglioside synthases. With the use of this procedure and GM3-acid affinity chromatography, the GD3 synthase was partially purified about 80 fold from a Lubrol PX extract of rat liver Golgi apparatus. The enzyme obtained had a pll optimum of 6.4. The preferred acceptors of the enzyme was GM3 containing N-acetylneuraminic acid (GM3 (NeuAc)) and GM3 containing N-glycolylneuraminic acid (GM3 (NeuGc)), with 2-fold higher V max in the latter than in the former. The Km values for GM3 (NeuAc), GM3 (NeuGc) and CMPNeuAc were 0.7 mM, 0.11 mM and 75 microM, respectively. The reaction product was identified as GD3 by thin layer chromatography. As to detergent, this enzyme showed maximum activity in 0.3% of Triton CF-54. The synthase did not require divalent cations for the activity, but rather Zn2+ and Cd2+ at 5 mM completely inhibited the enzyme activity.
Cytidine
nucleotides were strong inhibitors. The product, GD3, at 2 mM inhibited 30% the enzyme activity. The activity level of the GD3 synthase of rat liver was markedly different in rat strains, WKAH and TO strains being highest among eight strains examined. Male rat exhibited higher level than female. The synthase activity in rat liver was high at neonatal stage and decreased gradually thereafter.
...
PMID:[A study of partial purification of ganglioside GD3 synthase and its enzymatic properties]. 232 44
GMP-N-Acetylneuraminate: galactosyl-glycoprotein sialytransferase (CMP-N-acetylneuraminate: D-galactosyl-glycoprotein N-acetylneuraminyltransferase, EC 2.4.99.1) activity was identified in the human cervical epithelium. The enzyme has a pH optimum of 6.0, a temperature optimum of 28 degrees C, and demonstrates a partial requirement for Triton X-100. Michaelis constants for asialofetuin and CMP-N-acetyl[14C]neuraminic acid are 0.64 . 10(-5) M (expressed as the concentration of terminal galactose residues) and 2.05 . 10(-5) M, respectively. Sialytransferase demonstrated minimal affinity for the low molecular weight acceptors tested, and may have a requirement for a glycoprotein acceptor having a terminal N-acetyllactosamine (Gal beta (1 leads to 4)GlcNAc) type structure.
Cytidine
nucleotides are potent inhibitors of the
sialyltransferase
reaction; CMP acts as a competitive inhibitor.
...
PMID:Glycosyltransferases of the human cervical epithelium. II. Characterization of a CMP-N-acetylneuraminate: galactosyl-glycoprotein sialyltransferase. 616 92
Solid-phase assays for measuring the activity of four different glycosyltransferase enzymes that utilize N-acetyllactosamine as an acceptor are reported. These enzymes are alpha1,3-galactosyltransferase (E.C. 2.4.1.151), alpha1,3-fucosyltransferase (E.C. 2.4.1.65), alpha2,6-(N)-
sialyltransferase
(E.C. 2.4.99.1), and alpha2,3-(N)-
sialyltransferase
(E.C. 2.4.99.5). The acceptor is immobilized on a cellulose membrane in two different ways, through either an amine-cleavable linker or a photolinker. Incubation with a glycosyltransferase and nucleotide donor sugar resulted in the transfer of a monosaccharide from the donor to immobilized N-acetyllactosamine. For galactosyltransferase, transfer was confirmed by mass spectrometry of the products cleaved from the membrane surface after amine treatment or irradiation. When radioactive donors were utilized, the transfer of radioactive sugars could be monitored by autoradiography. Alternatively the transfer of radioactive sugar onto the membranes could be measured by scintillation counting of the products after cleavage from the membrane.
Cytidine
5(')-monophosphate-sialic acid carrying a fluorescent tag in the saccharide was also successfully utilized in this assay system. Fluorescent product on the membrane surface was detected by imaging. Glycosyltransferase assays with these versatile membranes have the potential to be adapted for high-throughput screening.
...
PMID:Glycosyltransferase assays utilizing N-acetyllactosamine acceptor immobilized on a cellulose membrane. 1462 51
Cytidine
-5'-monophospho-sialic acid (CMP-Neu5Ac) derivatives bearing a phenyl group in which the tether length between the phenyl group and the 9-position of Neu5Ac varied were synthesized and evaluated as substrates for sialyltransferases. In the synthesis of the compounds, a coupling reaction between methyl 5-acetamido-4,7,8-tri-O-acetyl-9-azido-3,5,9-trideoxy-beta-D-glycero-D-galacto-2-nonulopyranosonate and 2-cyanoethyl 2',3'-O,N4, triacetylcytidine-5'-yl N,N-diisopropylphosphoramidite was carried out and the phosphite derivative thus obtained was oxidized and then deprotected to yield CMP-9''-azido-Neu5Ac. Modification of the 9-amino group prepared by reduction of the azido groups was performed by the use of several phenyl-substituted alkylcarboxylic acid derivatives. Using these CMP-9''-modified-Neu5Ac analogues bearing the phenyl-substituted alkyl-amide group,
sialyltransferase
assays were performed with both rat liver alpha-(2-->6)-
sialyltransferase
and Photobacterium alpha-(2-->6)-
sialyltransferase
. These 9-modified analogues could be transferred to disaccharide acceptors, and a practical enzymatic synthesis using CMP-9''-modified-Neu5Ac yielded sialoside analogues and sialylglycoproteins in good yield. These experiments demonstrate that the Photobacterium
sialyltransferase
can be used in the synthesis of sialoside analogues having a large substituent at the 9-position of Neu5Ac.
...
PMID:Synthesis of CMP-9''-modified-sialic acids as donor substrate analogues for mammalian and bacterial sialyltransferases. 1757 99